The largest database of trusted experimental protocols

5 protocols using reca 1

1

Immunostaining of Cauda Equina and bEnd.3 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Frozen sections of cauda equine or fixed bEnd.3 cells were processed for immunostaining with antibodies against Jmjd3 (1:100, Abcam, Cambridge, MA, USA), ED-1 (CD68, 1:200; Serotec, Raleigh, NC, USA), RECA1 (1:100; Serotec, Raleigh, NC, USA), and ZO-1 (1:300, Invitrogen, Carlsbad, CA, USA) as previously described [19 (link)]. For double labeling, FITC or cy3-conjugated secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA) were used. Additionally, nuclei were labeled with DAPI according to the protocol of the manufacturer (Molecular Probes, Eugene, OR, USA). In all controls, reaction to the substrate was absent if the primary antibody was omitted or if the primary antibody was replaced by a non-immune, control antibody. Serial sections were also stained for histological analysis with Cresyl violet acetate. Fluorescence labeled signal was detected by a fluorescence microscope (BX51, Olympus, Japan), and capture of images and measurement of signal colocalization was determined by MetaMorph software (Molecular Devices, Sunnyvale, CA, USA). To count the number of macrophages, eight sections were selected at 1-mm intervals in the compressed region of the cauda equina, and the total number of ED-1-positive cells per section was averaged.
+ Open protocol
+ Expand
2

Liver Histological Assessment of I/R Injury

Check if the same lab product or an alternative is used in the 5 most similar protocols
Liver specimens were embedded in paraffin, cut into 5 μm sections, and stained with haematoxylin and eosin. The histological severity of I/R injury was graded using a modification of Suzuki’s criteria14 (link), as described in Table 1. The necrotic area was also quantitatively assessed using Image-Pro Plus v 6.0 (Media Cybernetics, Rockville, MD, USA). The results are presented as the percentage of necrotic area with respect to the entire area of the section. Immunostaining was performed for Ki-67 (BD Pharmingen, Franklin Lakes, NJ, USA) and cleaved caspase-3 (Cell Signaling Technology, Beverly, MA, USA) by staining with DAB followed by counter-staining with haematoxylin. The Ki-67 labelling index was determined as the percentage of Ki-67-positive hepatocytes per the total number of hepatocytes in 5 random visual fields (400×). Immunofluorescence was performed for rat endothelial cell antigen 1 (RECA-1) (Serotec, Oxford, UK).
+ Open protocol
+ Expand
3

Cerebrovascular Tracing Post Hypoxia-Ischemia

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cadaverine Alexa-488 (640Da; 200µg/pup, Invitrogen, Waltham, USA) or dextran of various molecular weights (3kD, 40kD and 70kD) was injected intravenously 1, 21, or 45 hours post H/I. Animals were sacrificed 3 hours following tracer infusions, perfused, and fixed with paraformaldehyde. Brains were removed and cut into 25 µm slices. Coronal brain sections were stained with RECA-1 (1:1000, AbD Serotec, Kidlington, UK) to visualize the cerebrovascular system. Fluorescence images were captured and the distribution of tracers was calculated using ImageJ software by a blinded observer.
+ Open protocol
+ Expand
4

Antibody Panel for Rat Immune Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse antirat monoclonal antibodies used in this study included ED1 (CD68), RECA-1 (endothelium), CD161 (NK cells), R73 (rat αβ T-cell receptor) (Serotec, Oxford, UK), as well as RP1 (neutrophils) (Becton Dickinson, San Diego, CA, USA). Other antibodies included rabbit antifibrinogen (Santa Cruz Biotechnology, Santa Cruz, CA, USA), fluorescein isothiocyanate-conjugated goat polyclonal antibodies against rat immunoglobulin G; (IgG; Sigma Aldrich, St. Louis, MO, USA), rabbit anti-C4d (Hycult Biotech, Plymouth Meeting, PA, USA), and Alexa594 conjugated donkey antirabbit IgG (Invitrogen, Carlsbad, CA, USA). Biotinylated secondary antibodies were goat antimouse IgG (Zymed, San Francisco, CA, USA) and goat antirabbit IgG (Invitrogen), which were detected using a Vectastain ABC kit (Vector Laboratories, Burlingame, CA, USA). Other secondary antibodies included horseradish peroxidase-conjugated goat antirabbit IgG, goat antimouse IgG, and mouse peroxidase-conjugated antiperoxidase complexes (all from Dako, Glostrup, Denmark). Tacrolimus was obtained in powder form from Selleck Chemicals (Houston, TX, USA).
+ Open protocol
+ Expand
5

Quantifying Vascular Density and VEGF in Myocardial Infarction

Check if the same lab product or an alternative is used in the 5 most similar protocols
The heart sections were stained with rat endothelial cell antigen-1 (RECA-1) (Serotec, Puchheim, Germany) and alphasmooth muscle actin (alpha-SMA) (Sigma, Missouri, USA) to analyze the arterial density. Briefly, the frozen slides were fixed in chilled 10% neutral buffered saline for 10 min at room temperature. After washing with 1X TBS-T, the slides were blocked with 10% goat serum for 30 min. The primary antibodies, RECA-1 (1:50) and alpha-SMA (1:100) were incubated overnight at 4 °C. After washing, secondary antibodies, Alexa-fluor 594 (1:500) and 488 (1:1000) were applied. The nuclei were then counterstained with Vectashield TM Hard Set mounting medium with DAPI. The RECA-1 and alpha-SMA positive vessels in 5 randomly selected fields were evaluated in the infarct zones and peri-infarct zones. The capillary and arterial densities were quantified in a blinded manner and the data were presented as the mean number of vessels per 200Â magnification field. VEGF (Abcam, USA) was stained using deparaffinized tissues that were treated with the same way as mentioned above at a working dilution factor of 1:100.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!